Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa

NCT00014729 is registered in ClinicalTrials.gov with University of North Carolina as lead sponsor.

NCT NCT00014729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00014729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa
Lead sponsor
University of North Carolina
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2000
Completion date
September 30, 2002
Enrollment
20
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epidermolysis bullosa